Zhenzhen Zhang

4PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 15, 2026
Post-Treatment Prognostic Nutritional Index Outperforms Baseline Index as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma Receiving Immune-Based Systemic Therapy.

|Apr 21, 2025
A Novel Nomogram Model for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection.

Yanfang Wu, Meixia Wang, Zhenzhen Zhang

|Mar 17, 2025
Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study.

Su-Su Zheng, Jing-Fang Wu, Zhen-Zhen Zhang

|Oct 27, 2022
Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization.

Yanfang Wu, Susu Zheng, Zhenzhen Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Guobin Chen

2 joint publications

Meixia Wang

1 joint publications

Yanfang Wu

1 joint publications

Hong Chen